Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Renin‐Angiotensin Aldosterone System Inhibitors and COVID‐19: A Systematic Review and Meta‐Analysis Revealing Critical Bias Across a Body of Observational Research

Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies, observational in design, appear to use biased methods that can distort the interaction between RAAS inhibitor use and COVID‐19 risk. This study assessed the extent of bias in that research and reevaluated RAAS inhibit...

Full description

Bibliographic Details
Main Authors: Jordan Loader, Frances C. Taylor, Erik Lampa, Johan Sundström
Format: Article
Language:English
Published: Wiley 2022-06-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
angiotensin receptor blockers
angiotensin‐converting enzyme inhibitors
calcium channel blockers
COVID‐19
renin‐aldosterone angiotensin system inhibitors
thiazide diuretics
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.025289

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.025289

Similar Items